India FSSAI Issues Notice to Dr. Reddy's and Nestle for Misleading GLP-1 Claims
Legal·1 article across 1 outlet
Story updated Rewritten when the story materially grows; the wire is checked every 15 minutesAbout this data
India’s federal food regulator issued a notice to the joint venture between Dr. Reddy’s Laboratories Ltd. and Nestle India Ltd. for misleading and ambiguous claims about its GLP-1 supplement.
The action highlights regulatory scrutiny over health supplements and their marketing practices in the country.
Dr. Reddy'sNestleFSSAI
Sources
Every quote below is verbatim from the article it is attributed to.
SourceReports the news
“India’s federal food regulator issued a notice to the joint venture between Dr. Reddy’s Laboratories Ltd. and Nestle India Ltd. for misleading and ambiguous claims about its GLP-1 supplement.”
Bloomberg — India FSSAI Acts Against GLP-1 Supplement for Misleading Claims